Braidwell LP

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
64
Total Value
2844802567
Accession Number
0001420506-25-001293
Form Type
13F-HR
CIK
0001920938
Manager Name
Braidwell LP
Data Enrichment
75% identified
48 identified16 unidentified

Holdings

64 positions
Manager:
SEC
Search and click to pin securities to the top
Page 2 of 4
TransMedics Group, Inc.
TMDX|89377M109
Shares:
854884(-7.3%)
Value:
$57.5B(+0.0%)
Guardant Health, Inc.
GH|40131M109
Shares:
1327327(-53.4%)
Value:
$56.5B(-35.0%)
Edgewise Therapeutics, Inc.
EWTX|28036F105
Shares:
2458808(+5.4%)
Value:
$54.1B(-13.1%)
Inspire Medical Systems, Inc.
INSP|457730109
Shares:
302410(+3.1%)
Value:
$48.2B(-11.4%)
10806XAD4
10806XAD4
Shares:
0
Value:
$43.8B(-4.7%)
45258DAB1
45258DAB1
Shares:
0
Value:
$43.8B
Kiniksa Pharmaceuticals International, plc
KNSA|G52694109
Shares:
1962909(-43.1%)
Value:
$43.6B(-36.1%)
INTUITIVE SURGICAL INC
ISRG|46120E602
Shares:
88000(+16.9%)
Value:
$43.6B(+10.9%)
Alphatec Holdings, Inc.
ATEC|02081G201
Shares:
4259429(+0.1%)
Value:
$43.2B(+10.5%)
Spyre Therapeutics, Inc.
SYRE|00773J202
Shares:
2578404(+0.0%)
Value:
$41.6B(-30.7%)
Blueprint Medicines Corp
BPMC|09627Y109
Shares:
439968
Value:
$38.9B
Dyne Therapeutics, Inc.
DYN|26818M108
Shares:
3621344(+431.6%)
Value:
$37.9B(+136.0%)
Apellis Pharmaceuticals, Inc.
APLS|03753U106
Shares:
1652334(-21.3%)
Value:
$36.1B(-46.0%)
Adaptive Biotechnologies Corp
ADPT|00650F109
Shares:
4803794
Value:
$35.7B
Viking Therapeutics, Inc.
VKTX|92686J106
Shares:
1435955(-3.0%)
Value:
$34.7B(-41.8%)
Penumbra Inc
PEN|70975L107
Shares:
110128(-40.1%)
Value:
$29.4B(-32.5%)
Bicara Therapeutics Inc.
BCAX|055477103
Shares:
2162803(+8.1%)
Value:
$28.2B(-19.1%)
Day One Biopharmaceuticals, Inc.
DAWN|23954D109
Shares:
3536853(-27.4%)
Value:
$28.0B(-54.6%)
ORTHOPEDIATRICS CORP
KIDS|68752L100
Shares:
1107770(+0.0%)
Value:
$27.3B(+6.3%)
HARROW, INC.
HROW|415858109
Shares:
956839(+5.5%)
Value:
$25.5B(-16.4%)